Neupath Health Stock Current Valuation
| NPTH Stock | CAD 0.20 0.02 11.11% |
Valuation analysis of NeuPath Health helps investors to measure NeuPath Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, NeuPath Health's Cash is fairly stable compared to the past year. Change In Cash is likely to climb to about 1.6 M in 2025, despite the fact that Total Cash From Financing Activities is likely to grow to (2.5 M). Fundamental drivers impacting NeuPath Health's valuation include:
Price Book 0.508 | Enterprise Value 19.5 M | Enterprise Value Ebitda 6.6741 | Price Sales 0.1555 | Forward PE 6.6445 |
Overvalued
Today
Please note that NeuPath Health's price fluctuation is out of control at this time. Calculation of the real value of NeuPath Health is based on 3 months time horizon. Increasing NeuPath Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NeuPath stock is determined by what a typical buyer is willing to pay for full or partial control of NeuPath Health. Since NeuPath Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NeuPath Stock. However, NeuPath Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 0.18 | Hype 0.2 | Naive 0.21 |
The intrinsic value of NeuPath Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NeuPath Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NeuPath Health helps investors to forecast how NeuPath stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NeuPath Health more accurately as focusing exclusively on NeuPath Health's fundamentals will not take into account other important factors: NeuPath Health Company Current Valuation Analysis
NeuPath Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NeuPath Health Current Valuation | 19.52 M |
Most of NeuPath Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeuPath Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NeuPath Health has a Current Valuation of 19.52 M. This is 99.86% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Canada stocks is 99.88% higher than that of the company.
NeuPath Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeuPath Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NeuPath Health could also be used in its relative valuation, which is a method of valuing NeuPath Health by comparing valuation metrics of similar companies.NeuPath Health is currently under evaluation in current valuation category among its peers.
NeuPath Fundamentals
| Return On Equity | -0.0308 | ||||
| Return On Asset | 0.017 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 19.52 M | ||||
| Shares Outstanding | 56.4 M | ||||
| Shares Owned By Insiders | 1.24 % | ||||
| Shares Owned By Institutions | 24.34 % | ||||
| Number Of Shares Shorted | 12.5 K | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 0.16 X | ||||
| Revenue | 66.1 M | ||||
| Gross Profit | 13.46 M | ||||
| EBITDA | 2.16 M | ||||
| Net Income | (107 K) | ||||
| Cash And Equivalents | 7.48 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 195 K | ||||
| Debt To Equity | 0.67 % | ||||
| Current Ratio | 1.27 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | 3.03 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.5 | ||||
| Number Of Employees | 156 | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 11 M | ||||
| Total Asset | 41.78 M | ||||
| Retained Earnings | (26.02 M) | ||||
| Working Capital | 1.51 M | ||||
| Net Asset | 41.78 M |
About NeuPath Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeuPath Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuPath Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuPath Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.